Design rights are becoming increasingly valuable for companies in today’s world, covering everything from the shapes of our mobile phones to the designs of consumer products...
Hamilton Brook Smith Reynolds was recognized by IAM Patent 1000 as a top patent firm both nationally and in Massachusetts for quality patent prosecution services. Principals Susan...
The new Federal Trade Commission ban on noncompete agreements will unleash two contradictory threads: more innovation and inventions, and more intellectual property theft...
On March 1, 2024, updated Guidelines for examining AI inventions at the European Patent Office (EPO) came into effect. These updated guidelines can be found in the official “...
Hamilton Brook Smith Reynolds is a proud, longstanding annual sponsor of the Medical Development Group of Boston (MDG Boston). For years, Hamilton Brook Smith Reynolds has played a...
Hamilton Brook Smith Reynolds is excited to share that we are now an annual sponsor of the UMass Lowell Innovation Hub. The UMass Lowell Innovation Hub (UML iHub) offers premier coworking...
The United States Patent and Trademark Office (USPTO) recently published guidance on whether a natural person may be an inventor of an AI-assisted invention. This guidance from...
The jury in the recent Sedlik v. Von Drachenberg case decided that a tattoo of jazz trumpeter Miles Davis inked by celebrity artist Kat Von D was not substantially similar to a copyrighted...
Best practices continue to include providing enabling disclosure reasonable for claim scope, including disclosure of structural characteristics common to all claimed embodiments of...
World Trademark Review (WTR) 1000, the world’s leading review of trademark professionals, has recognized Hamilton Brook Smith Reynolds in the Silver category for the fourteenth...
Mary Lou Wakimura, Principal and Chair of the Board of Directors of Hamilton Brook Smith Reynolds, was recently interviewed as the first guest in MDG Boston’s new video...
Rob earned his Ph.D. in Bioorganic Chemistry from the University of Rochester where he focused on leveraging P450 enzymes to modify various natural products and drug molecules...